Major US university system active in MSCA mobility programmes, contributing cancer biomarker research, computational geophysics, and nanomaterials expertise to European consortia.
The University of Texas System is a major US public university system with broad research capabilities spanning biomedical sciences, computational methods, nanotechnology, and social sciences. Within H2020, it primarily serves as a non-EU third-party partner in MSCA staff exchange and mobility programmes, providing American research infrastructure and expertise to European consortia. Its strongest contributions are in cancer biology and biomarker research (liver cancer, hepatocellular carcinoma, immunotherapy), advanced numerical simulation for geophysical applications, and nanomaterial science. It functions as an international knowledge bridge, enabling researcher mobility between US and European institutions.
HEPCIR (liver cancer biomarkers), RNADIAGON (non-coding RNA diagnostics in oncology), PICModForPCa (prostate cancer modelling), SUPRO-GEN (gene vectors for cancer therapy), MAGNAMED (cancer diagnostics), iReceptor Plus (cancer immunotherapy)
GEAGAM (Galerkin methods for geophysics), MATHROCKS (porous rock physics simulation), GEODPG (space-time DPG methods), DRIVEN (data-driven simulation)
SONAR (doped semiconductor nanocrystals), MAGNAMED (magnetic nanostructures), NOCTURNO (wave propagation for sensing technologies)
TACTILENet (autonomous large-scale IoT networks) and WINDMILL (integrating wireless engineering with machine learning, 5G, massive MIMO)
COLING (minority language revitalization), WoMoGeS (gestational surrogacy policy), LGBTQ Parenthood (cross-national perspectives), RelImprecision (relational contracting)
In the early period (2015–2018), UT System's H2020 involvement centred on life sciences fundamentals — liver disease pathways, biomaterial science, plasmon resonance in nanomaterials, and magnetic nanostructures for biomedical use. From 2019 onward, the focus shifted toward translational and data-intensive research: cancer immunotherapy and immune repertoire analysis (iReceptor Plus), computational oncology (PICModForPCa), RNA-based diagnostics (RNADIAGON), and environmental/planetary health topics. The trend shows a move from foundational materials and cell biology toward applied, data-driven biomedical research with clinical relevance.
UT System is increasingly oriented toward data-driven biomedical research — cancer immunotherapy, computational oncology, and RNA diagnostics — making them a strong future partner for precision medicine consortia.
UT System never coordinates H2020 projects — it participates exclusively as a third-party partner (25 of 31 projects) or named participant (6 projects), reflecting its role as a non-EU associated partner brought in for international expertise and researcher exchange. With 243 unique consortium partners across 46 countries, it operates as a high-connectivity hub rather than a loyal repeat-partner organisation. This makes them easy to onboard into new consortia: they are experienced with EU project mechanics, comfortable in large international teams, and accustomed to the MSCA mobility format.
An exceptionally broad network spanning 243 partners across 46 countries, built almost entirely through MSCA staff exchange programmes. This gives UT System one of the widest geographic reach profiles of any US-based H2020 participant, though connections tend to be mobility-oriented rather than deep co-development partnerships.
As a large US university system deeply embedded in European MSCA networks, UT System offers something most American institutions do not: proven experience navigating H2020 consortium structures across 31 projects. For European coordinators building consortia that need a credible US partner for international dimension — particularly in biomedical research, computational methods, or nanomaterials — UT System is a low-risk choice with a well-established track record. Their breadth across disciplines also means they can contribute researchers from multiple departments to interdisciplinary projects.
